The 2019 American Society of Clinical Oncology (ASCO) Annual Meeting is being held in Chicago, Illinois, from May 31 through June 4, offering a program that is designed to teach, engage, and bring the oncology field together.
2019 ASCO Annual Meeting
Curated Oncology Journal Abstracts
According to the @icocancer's work presented at #ASCO2019, the multiparametric method of screening for #DPD deficiency is clearly the most effective for preventing #5FU toxicity and death.
https://t.co/FU3VnGuWnj
Selon les travaux de l'@icocancer présentés au congrès de l'#ASCO2019, la méthode multiparamétrique de dépistage des déficits en DPD est significativement la plus efficace pour prévenir les risques de toxicités à la suite d’un traitement à base de #5FU.
https://t.co/FU3VnGuWnj
Este año aprendí que para la gente es más fácil echarte la culpa por las malas decisiones (drogas, fiestas, relajos, y +) a otros, que hacerse cargo de sus cagadas. #Asco2019
@AshleySumrallMD Hallo you can read it here: Thread by @AshleySumrallMD: "Tweetorial: NTRK 101 Given the data discussed at @asco & @sno on fusions in primary brain t […]" #ASCO2019 #SNO2019 https://t.co/oUv8YxHTw4
Enjoy 🙂 🤖
🚨Tweetorial: NTRK 101 🚨Given the data discussed at @asco #ASCO2019 & @sno #SNO2019 on #NTRK fusions in primary brain tumors & brain mets, I thought we could review the background of these fusions, how to find them, and then look at potential options for tx. #btsm
This was my FAVE slide at @asco #ASCO2019 presented by my friend & mentor, Dr Skip Grossman, of @hopkinskimmel. So glad to see Dr Wen present it at #SNO2019 #btsm No more dead horses! I’m looking at you, Bevacizumab.
A great bit of wisdom for neuro-oncologists searching for new therapies...😆 Featured during Dr. Patrick Wen's award lecture at @NeuroOnc #sno2019 #BTSM